Acurx Pharmaceuticals, Inc. (ACXP) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$6.79M | +34.6% |
| 2024 | -$10.38M | -5.9% |
| 2023 | -$9.80M | -29.9% |
| 2022 | -$7.54M | -50.4% |
| 2021 | -$5.01M | -49.6% |
| 2020 | -$3.35M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$6.79M | +34.6% |
| 2024 | -$10.38M | -5.9% |
| 2023 | -$9.80M | -29.9% |
| 2022 | -$7.54M | -50.4% |
| 2021 | -$5.01M | -49.6% |
| 2020 | -$3.35M | — |